Sample Detail | Central BioHub GmbH: Order Human Biospecimens Online

Product Page

CBH Donor ID CBH Sample ID Matrix Quantity (Unit) Age Gender Price Cart
CBHD1508111 CBHS1508114 Serum 180 (ml) not specified 7500

Samples will be shipped within 5 to 10 business days.

General Data
CBH Donor ID
CBH Master ID
CBH Sample ID
Matrix
Storage Container
Storage Temperature
Freeze Thaw Cycles
Infectious Disease Test Result
Infectious Disease Test Remarks
Sample Condition

CBHD1508111
CBHM1508111
CBHS1508114
Serum
 
= -15°C
 
negative
Each individual donation has been tested with methods cleared in compliance with European Directive 98/79/EC and found negative for HBsAg. anti-HIV I+II. anti-HCV. HIV I RNA. HCV RNA. HBV DNA. Syphilis.
 
Quantity Information
Quantity
Unit
Total Quantity

180
ml
180
Donor
Age
Gender
Ethnicity
Ethnicity Remarks
BMI
Height
Height Unit
Weight
Weight Unit
Blood Type
Rhesus Factor

not specified
 
 
 
 
 
 
 
 
 
 
Laboratory
Lab Parameter
Lab Parameter Remarks
Result Measured In
Result Obtained From
Result Raw
Result Numerical
Result Numerical Range
Result Unit
Result Interpretation
Result Remarks
Result Date
Cut Off Raw
Cut Off Unit
X Time Cut Off
Cut Off Remarks
Test Method
Test Remarks
Test Kit
Test Kit Manufacturer
Test System
Test System Manufacturer

SARS-CoV-2 Spike IgG
 
 
 
 
 
 
 
positive
 
 
 
 
 
 
 
 
 
 
 
 
Clinical Diagnosis
Diagnosis
Diagnosis Remarks
ICD Code
ICD Code Version
ICD Code Translation
Diagnosis Date
Pregnancy Week
Pregnancy Trimester

COVID-19. convalesced
SARS-CoV-2 infection determined by positive PCR result
 
 
 
 
 
 
Histology
Histological Diagnosis
Organ
Disease Presentation
Tissue Size
Tumour Size
TNM Class T
TNM Class N
TNM Class M
LVI Class L
LVI Class V
Tumour Grade
Tumour Stage
Viable Cells per
Necrotic Cells per
Tumour Cells per
Proliferation Rate Ki67 per
Estrogen Receptor
Progesteron Receptor
HER 2 Receptor
Other Gene Mutations

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Treatment
Medication
Medication Remarks
Medication Administration
Medication Dose
Medication Dose Unit
Medication Start
Medication End
Medication Discontinuation Cause
Therapy
Therapy Remarks
Therapy Start
Therapy End

 
 
 
 
 
 
 
 
 
 
 
 
Drug Abuse
Drug of Abuse
Smoking Status
Smoking Remarks
Alcohol Consumption

 
 
 
 
Anamnesis Information
Anamnesis
Anamnesis Question
Anamnesis Value
Anamnesis Unit
Anamnesis Remarks
Anamnesis Date

 
 
 
 
 
 
Preanalytics
Country of Collection
Date of Collection
Collection System
Cold Ischemia Time
Sample Processing
Fixative Type
Fixation Time
Collection to Processing Time
Collection to Processing Time Unit
Processing to Freezing Time
Processing to Freezing Time Unit

 
 
 
 
 
 
 
 
 
 
 
Ethics
Procurement Type
Informed Consent
Designated Use

 
yes
 
Specific Products
Product Name
Samples per Product
Product Specification
Product Count

SARS-CoV-2 Spike IgG Serum Bulk
1
Native patient samples | SARS-CoV-2 recovered donors | detailed patient documentation (information about: age. gender. symptoms during infection. measured laboratory results and more) | no symptoms during blood donation | Optional: negative PCR result at the moment of blood donation. determination of antibody titer (Spike IgG)
10